United Therapeutics Corp (UTHR) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 6.28%832.50 | 783.30 | 781.50 | 790.20 | 799.50 |
| Cost Of Revenue | 0.40%99.10 | 99.50 | 133.40 | 103.40 | 100.90 |
| Gross Profit | 7.25%733.40 | 683.80 | 648.10 | 686.80 | 698.60 |
29.17%146.40 | 206.70 | 184.10 | 190.60 | 182.60 | |
| Selling, General, and Administrative | 29.17%146.40 | 206.70 | 184.10 | 190.60 | 182.60 |
| Research and Development | 90.84%279.20 | 146.30 | 138.20 | 139.50 | 127.50 |
| Costs And Expenses | 15.96%524.70 | 452.50 | 455.70 | 433.50 | 411.00 |
| Operating Income/Loss | 6.95%307.80 | 330.80 | 325.80 | 356.70 | 388.50 |
| Nonoperating Income/Loss | 55.13%65.00 | 41.90 | -7.50 | 87.30 | 49.50 |
| Income/Loss From Continuing Operations Before Tax | 0.03%372.80 | 372.70 | 318.30 | 444.00 | 438.00 |
| Income Tax Expense/Benefit, Deferred | 88.72%48.50 | 25.70 | 25.90 | - | - |
| Income Tax Expense/Benefit | 187.66%114.20 | 39.70 | 43.40 | 79.70 | 99.30 |
22.34%258.60 | 333.00 | 274.90 | 364.30 | 338.70 | |
| Attributable To Parent | 22.34%258.60 | 333.00 | 274.90 | 364.30 | 338.70 |
| Basic Average Shares | 0.23%42.70 | 42.60 | 43.50 | - | 43.80 |
| Diluted Average Shares | 1.09%45.30 | 45.80 | 47.20 | - | 47.30 |
| Basic Earnings Per Share | 22.51%6.06 | 7.82 | 6.32 | - | 7.73 |
| Diluted Earnings Per Share | 21.46%5.71 | 7.27 | 5.82 | - | 7.16 |